Oxford BioMedica (GB:OXB) has released an update.
Oxford Biomedica PLC announced the successful passage of all proposed resolutions during their Annual General Meeting held on June 24, 2024, with each resolution decided by a poll vote. The resolutions included approvals for the appointment and reappointment of several company directors, the adoption of financial reports, and the implementation of incentive plans. Additionally, Dr. Michael Hayden and Catherine Moukheibir stepped down from the Board of Directors following the meeting.
For further insights into GB:OXB stock, check out TipRanks’ Stock Analysis page.
